Clinical Trial - Trial jRCT2031230352
Access comprehensive clinical trial information for jRCT2031230352 through Pure Global AI's free database. This phase not specified trial is sponsored by Janssen Pharmaceutical K.K. and is currently Not yet recruiting. The study focuses on Crohn's Disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2031230352
Not yet recruiting
Trial Details
Japan Registry Clinical Trial • jRCT2031230352
Untitled Trial
A Phase 3, Multicenter, Randomized, Platform Study of p19 Inhibition of the IL 23 Pathway to Establish Efficacy in Pediatric Crohn's Disease (MACARONI 23)
Study Focus
Interventional
Sponsor & Location
Janssen Pharmaceutical K.K.
Australia;Belgium;Brazil;Canada;Switzerland;Czech;Spain;France;United Kingdom of Great Britain;Israe
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Crohn disease, unspecified
Other Crohn disease
Crohn disease of large intestine
Crohn disease [regional enteritis]
Crohn disease of small intestine
Data Source
Japan Registry Clinical Trial
jRCT2031230352
Non-Device Trial